Form 4: BioLife Solutions Executive Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4


Sarah Aebersold, Chief Human Resources Officer of BioLife Solutions, sold 345 shares of common stock on May 29, 2024, to satisfy tax withholding obligations related to vesting restricted stock.

Summary

  • On May 29, 2024, Sarah Aebersold, the Chief Human Resources Officer of BioLife Solutions Inc., sold 345 shares of the company's common stock.
  • The sale was executed at a price of $21.78 per share.
  • This transaction was conducted under a pre-arranged Rule 10b5-1(c) trading plan adopted on February 24, 2022.
  • The purpose of the sale was to cover tax withholding obligations associated with the vesting of restricted stock.
  • Following the transaction, Aebersold directly owns 64,683 shares of BioLife Solutions Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transaction is a routine sale of shares to cover tax obligations and was pre-planned.

Positives

  • The sale was conducted under a pre-arranged Rule 10b5-1(c) trading plan, indicating it was planned and not based on immediate market conditions.

Industry Context

Sales of shares by company executives are a normal part of corporate governance. Often these sales are planned in advance to avoid any perception of insider trading.

Stakeholder Impact

  • The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale and the pre-planned nature of the transaction.

Key Dates

DateDescription
02/24/2022Date of adoption of Rule 10b5-1(c) trading plan
05/29/2024Date of stock sale transaction
05/31/2024Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.